Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13101-13112
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13101
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13101
Table 2 Lesions and treatment outcomes
Variables | Total lesions (n = 95) | Size (mm) | Radiation (Gy) | Response | |||||||
n | Median | Range | Dose | Range | Fraction | CR | PR | SD | PD | NA | |
Liver | |||||||||||
Portal vein | 9 | 34.5 | (15-54) | 36 | (28-50) | (3-6) | 2 | 2 | 1 | 4 | |
Hepatic vein | 4 | 38 | (20-54) | 32.1 | (28-36) | (4-10) | 1 | 1 | 1 | 1 | |
Bile duct | 4 | 19.5 | (12-29) | 38.5 | (28-45) | (5-7) | 1 | 1 | 2 | ||
Bone | 52 | 24.5 | (10-52) | 21.5 | (8-33) | (1-6) | 1 | 13 | 16 | 11 | 11 |
Lung | 9 | 19 | (18-48) | 40 | (27-48) | (3-4) | 4 | 1 | 4 | ||
Brain | 7 | 23.5 | (12-38) | 22 | (14-30) | (1-3) | 2 | 2 | 3 | ||
Others | 10 | 31 | (15-53) | 30 | (16-48 | (1-6) | 1 | 6 | 3 |
- Citation: Kato H, Yoshida H, Taniguch H, Nomura R, Sato K, Suzuki I, Nakata R. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma. World J Gastroenterol 2015; 21(46): 13101-13112
- URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13101.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i46.13101